Bacterial Genetics Core D
细菌遗传学核心 D
基本信息
- 批准号:10271482
- 负责人:
- 金额:$ 40.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-01 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:AchievementAgeAntibioticsBacterial GenesBase PairingBiochemicalBiologicalCRISPR interferenceClinical Drug DevelopmentDevelopmentDrug TargetingDrug resistanceDrug resistance in tuberculosisEssential GenesGene ProteinsGene SilencingGene TargetingGenerationsGenesGeneticGenetic TranscriptionGenomeGrowthGuide RNAHumanImmune responseImmune systemIndividualLaboratoriesLengthLibrariesLipidsM. tuberculosis genomeMediator of activation proteinMetabolicMethodsMicrobiologyMulti-Drug ResistanceMutationMycobacterium tuberculosisNatureNucleotidesOpen Reading FramesOrganismPatientsPharmaceutical PreparationsPhenotypeProductionProteinsRNAResearchRifampicin resistanceRoleSignal Transduction PathwayTechnologyVariantVirulenceVirulence FactorsWorkbacterial geneticsdesigndesign and constructionexperimental studygenetic manipulationgenome-widein vivointerestknock-downknockout genelipidomicsmutantmycobacterialnovelnovel strategiesnucleaseprogramsresponsescreeningsmall moleculestem
项目摘要
Core D. Bacterial Genetics Core
Core Leader: Jeremy Rock
ABSTRACT
Stewart Cole and colleagues determined the complete genome sequence of Mycobacterium tuberculosis (Mtb)
in 1998 (1). This landmark achievement heralded a new age in mycobacterial research, including the
development of organism-wide gene knockout and knockdown technologies that made it possible to determine
the roles of specific mycobacterial genes in survival and host response. However, despite the ability to
interrogate thousands of new potential targets, few new genes have advanced as targets for active clinical
drug development. This shortfall stems, in part, from key technical limitations in the ability to systematically
interrogate the Mtb genome on an organism-wide basis. To help overcome this limitation, Jeremy Rock and
colleagues developed CRISPRi interference (CRISPRi) technologies that achieve robust, programmable gene
silencing in Mtb. The Rock laboratory has now validated a genome-scale library of 96,700 independent
CRISPRi mutants, which comprise the central technology of the Bacterial Genetics Core D. These efforts have
resulted refined CRISPRi design rules, allowing the generation of highly efficacious and specific CRISPRi
knockdown for nearly all Mtb genes, including methods for titratable knockdown of essential genes. The
Bacterial Genetics Core will support Project 1 by designing and constructing individual and pools of Mtb
CRISPRi mutants to identify new lipids that are downstream of genes involved in virulence, barrier function and
Mtb strain variations in human patients. Core D will support Project 2 by providing genetic mutants within the
MtrAB signal transduction pathway, a central mediator of intrinsic multi-drug resistance in Mtb. In addition,
CRISPRi will be used to silence genes involved in the mycobacterial drug response, intrinsic drug resistance to
rifampicin, as well as Mtb envelope composition. These studies will identify novel genetic and biochemical
targets for development of new anti-mycobacterial drugs. Further, these experiments inform strategies for
augmenting the efficacy of existing drugs through targeting bacterial genes that modulate the sensitivity of Mtb
to antibiotics.
核心D.细菌遗传学核心
核心领袖:杰里米·洛克
摘要
斯图尔特·科尔和他的同事确定了结核分枝杆菌(Mtb)的完整基因组序列。
1998年(1)。这一里程碑式的成就预示着分枝杆菌研究进入了一个新时代,包括
生物体范围的基因敲除和敲除技术的发展使其能够确定
特定分枝杆菌基因在生存和宿主反应中的作用。然而,尽管有能力
询问数千个新的潜在靶点,几乎没有新基因作为活跃临床的靶点
药物开发。这一不足的部分原因是,在系统地
在整个生物体的基础上询问结核分枝杆菌基因组。为了帮助克服这一限制,杰里米·洛克和
同事们开发了CRISPRi干扰(CRISPRi)技术,实现了强大的、可编程的基因
Mtb中的静音。Rock实验室现在已经验证了一个包含96,700个独立基因组规模的文库
CRISPRi突变体,它们构成了细菌遗传学核心D的核心技术。这些努力
最终改进了CRISPRi设计规则,允许生成高效和特定的CRISPRi
几乎所有结核分枝杆菌基因的敲除,包括可滴定敲除必要基因的方法。这个
细菌遗传学核心将通过设计和建造结核分枝杆菌个体和池来支持项目1
CRISPRi突变体识别毒力、屏障功能和致病相关基因下游的新脂质
人类患者中结核分枝杆菌菌株的变异。核心D将支持项目2,方法是在
MtrAB信号转导通路是结核分枝杆菌固有多药耐药的中枢调节因子。此外,
CRISPRi将被用来沉默参与分枝杆菌药物反应的基因,内在的耐药性
利福平,以及结核分枝杆菌包膜成分。这些研究将确定新的遗传和生化
抗分枝杆菌新药的开发目标。此外,这些实验为以下策略提供了信息
通过靶向调节结核分枝杆菌敏感性的细菌基因来增强现有药物的疗效
到抗生素。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeremy Michael Rock其他文献
Jeremy Michael Rock的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeremy Michael Rock', 18)}}的其他基金
Molecular mechanisms of inherent drug resistance in non-tuberculous mycobacteria
非结核分枝杆菌固有耐药性的分子机制
- 批准号:
10771645 - 财政年份:2023
- 资助金额:
$ 40.26万 - 项目类别:
Towards a molecular understanding of persistent tuberculosis infection
对持续性结核感染的分子理解
- 批准号:
9554177 - 财政年份:2018
- 资助金额:
$ 40.26万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政策的情绪动态
- 批准号:
10108433 - 财政年份:2024
- 资助金额:
$ 40.26万 - 项目类别:
EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
- 批准号:
MR/X032809/1 - 财政年份:2024
- 资助金额:
$ 40.26万 - 项目类别:
Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
- 批准号:
MR/X034690/1 - 财政年份:2024
- 资助金额:
$ 40.26万 - 项目类别:
Fellowship
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341426 - 财政年份:2024
- 资助金额:
$ 40.26万 - 项目类别:
Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341424 - 财政年份:2024
- 资助金额:
$ 40.26万 - 项目类别:
Continuing Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
- 批准号:
2335955 - 财政年份:2024
- 资助金额:
$ 40.26万 - 项目类别:
Standard Grant
The economics of (mis)information in the age of social media
社交媒体时代(错误)信息的经济学
- 批准号:
DP240103257 - 财政年份:2024
- 资助金额:
$ 40.26万 - 项目类别:
Discovery Projects
How age & sex impact the transcriptional control of mammalian muscle growth
你多大
- 批准号:
DP240100408 - 财政年份:2024
- 资助金额:
$ 40.26万 - 项目类别:
Discovery Projects
Supporting teachers and teaching in the age of Artificial Intelligence
支持人工智能时代的教师和教学
- 批准号:
DP240100111 - 财政年份:2024
- 资助金额:
$ 40.26万 - 项目类别:
Discovery Projects
Enhancing Wahkohtowin (Kinship beyond the immediate family) Community-based models of care to reach and support Indigenous and racialized women of reproductive age and pregnant women in Canada for the prevention of congenital syphilis
加强 Wahkohtowin(直系亲属以外的亲属关系)以社区为基础的护理模式,以接触和支持加拿大的土著和种族育龄妇女以及孕妇,预防先天梅毒
- 批准号:
502786 - 财政年份:2024
- 资助金额:
$ 40.26万 - 项目类别:
Directed Grant